Cell and Gene Therapy 01/03/2019 Phacilitate Automation Special Interest Group: 2018 Report The 2018 instalment of the Automation SIG identified the biggest hurdles facing our industry. This report summarises the onsite discussions and findings, as well as a series of recommendations to ensure we move forward and progress
Cell and Gene Therapy 19/02/2019 Guest Blog: Are we Facing a COGs Crisis? Some insights from Phacilitate Leaders World 2019 by Stacey Johnson, CCRM
Cell and Gene Therapy 06/02/2019 The Top Ten Events in Advanced Therapies 2018 From CRISPR patent wars, IPOs and acquisitions to major deals in China; what would be on your top ten list of 2018?
Cell and Gene Therapy 24/01/2019 Behind the Scenes at Phacilitate Leaders World 2019 The story so far...
Cell and Gene Therapy 12/12/2018 Advanced Therapy Manufacturing: The Supply Chain Challenge Advanced therapy manufacturing and supply chains are anything but conventional
Cell and Gene Therapy 03/12/2018 Industrializing Advanced Therapies Changing mindsets to drive efficient manufacturing and commercialization of advanced therapies
Cell and Gene Therapy 28/11/2018 Demystifying the Common Technical Document Top tips for completing the common technical document for advanced therapies with Chris Bravery, Consulting Regulatory...
Cell and Gene Therapy 28/11/2018 The Clinician’s Perspective on Patient Access Two healthcare professionals give their views on delivering advanced therapies in the clinic...
Cell and Gene Therapy 09/11/2018 Understanding Global, Complex Supply Chains for Advanced Therapies A snapshot of the supply chain, logistics and customs challenges for advanced therapies
Cell and Gene Therapy 08/10/2018 FDA Regulatory Reform? An interview with Anthony Davies, Founder and CEO, Dark Horse Consulting
Cell and Gene Therapy 01/10/2018 [INTERVIEW] An Academic Perspective on Cell Therapy, Trial Design... An interview with Dr David Courtman of the Ottawa Hospital, the University of Ottawa and Northern Therapeutics
Cell and Gene Therapy 20/09/2018 60 seconds with...Detlev Parow, DAK-Gesundheit A Payer’s Perspective on CAR-T Pricing and Reimbursement
Cell and Gene Therapy 12/09/2018 The Evolution of Advanced Therapies: A 200-Year History 200 years of milestones and achievements that have led to today's advanced therapies industry
Cell and Gene Therapy 06/09/2018 We’re answering this year’s question with a firm “maybe!” A guest blog from Stacey Johnson, Director, Communications and Marketing at CCRM and Phacilitate:Exchange editorial board member
Cell and Gene Therapy 31/08/2018 WEBINAR: Avoid Tripping at the Last Mile Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last...
